Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DeepSwitch: Switching from Atripla to Eviplera in HIV
NCT02447016Phase 4Terminated
- Sponsor
- Sheba Medical Center
- Start
- May 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of emtricitabine + rilpivirine + tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV), sponsored by Sheba Medical Center. Started May 2015; status: terminated.
02
Drugs
emtricitabine + rilpivirine + tenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02447016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02447016.